Market Chatter: South Korean Regulator Rejects Thelma Therapeutics's Phase Three Trial for COVID-19 Cure-- Thelma Therapeutics has been denied by South Korea's Ministry of Food and Drug Safety to proceed with its phase three clinical trial on its investigational COVID-19 cure candidate Neovir-CoV,...